199 related articles for article (PubMed ID: 34031902)
1. COVID-19 in patients with myasthenia gravis: Epidemiology and disease course.
Businaro P; Vaghi G; Marchioni E; Diamanti L; Arceri S; Bini P; Colombo E; Cosentino G; Alfonsi E; Costa A; Ravaglia S; Mallucci G; Ballante E; Franciotta D; Gastaldi M
Muscle Nerve; 2021 Aug; 64(2):206-211. PubMed ID: 34031902
[TBL] [Abstract][Full Text] [Related]
2. The impact of SARS-CoV-2 immunization on COVID-19 disease course in people with myasthenia gravis.
Bakirtzis C; Boziki MK; Karakasi MV; Moysiadis T; Grigoriadis N
Muscle Nerve; 2023 May; 67(5):412-416. PubMed ID: 36814101
[TBL] [Abstract][Full Text] [Related]
3. Case series of COVID-19 in patients with myasthenia gravis: a single institution experience.
Županić S; Perić Šitum M; Majdak M; Karakaš M; Bašić S; Sporiš D
Acta Neurol Belg; 2021 Aug; 121(4):1039-1044. PubMed ID: 33797054
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study.
Rzepiński Ł; Zawadka-Kunikowska M
Neurol Neurochir Pol; 2022; 56(1):61-67. PubMed ID: 34346049
[TBL] [Abstract][Full Text] [Related]
5. Risk and course of COVID-19 in immunosuppressed patients with myasthenia gravis.
Stascheit F; Grittner U; Hoffmann S; Mergenthaler P; Schroeter M; Ruck T; Pawlitzki M; Blaes F; Kaiser J; Schara U; Della-Marina A; Thieme A; Hagenacker T; Jacobi C; Berger B; Urban PP; Knop KC; Schalke B; Lee DH; Kalischewski P; Wiendl H; Meisel A
J Neurol; 2023 Jan; 270(1):1-12. PubMed ID: 36166068
[TBL] [Abstract][Full Text] [Related]
6. Safety of mRNA COVID-19 vaccines in patients with well-controlled myasthenia gravis.
Gamez J; Gamez A; Carmona F
Muscle Nerve; 2022 Nov; 66(5):612-617. PubMed ID: 36029224
[TBL] [Abstract][Full Text] [Related]
7. Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19.
Gungor Tuncer O; Deymeer F
Muscle Nerve; 2022 Apr; 65(4):447-452. PubMed ID: 35040147
[TBL] [Abstract][Full Text] [Related]
8. Impact of Coronavirus Disease 2019 in a French Cohort of Myasthenia Gravis.
Solé G; Mathis S; Friedman D; Salort-Campana E; Tard C; Bouhour F; Magot A; Annane D; Clair B; Le Masson G; Soulages A; Duval F; Carla L; Violleau MH; Saulnier T; Segovia-Kueny S; Kern L; Antoine JC; Beaudonnet G; Audic F; Kremer L; Chanson JB; Nadaj-Pakleza A; Stojkovic T; Cintas P; Spinazzi M; Foubert-Samier A; Attarian S
Neurology; 2021 Apr; 96(16):e2109-e2120. PubMed ID: 33568541
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival.
Jakubíková M; Týblová M; Tesař A; Horáková M; Vlažná D; Ryšánková I; Nováková I; Dolečková K; Dušek P; Piťha J; Voháňka S; Bednařík J
Eur J Neurol; 2021 Oct; 28(10):3418-3425. PubMed ID: 34080271
[TBL] [Abstract][Full Text] [Related]
10. COVID-19 infection in myasthenia gravis: Clinical course and outcomes.
Thomas EV; Bou G; Barton S; Hutto S; Garcia-Santibanez R
Muscle Nerve; 2023 Aug; 68(2):171-175. PubMed ID: 37326164
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 in patients with myasthenia gravis: a single-center retrospective study in China.
Li J; Zheng Y; Zhao Y; Qi K; Lin G; Liu R; Hao H; Wang Z; Yuan Y; Gao F
Neurol Sci; 2024 Jul; 45(7):2969-2976. PubMed ID: 38652194
[TBL] [Abstract][Full Text] [Related]
12. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
[TBL] [Abstract][Full Text] [Related]
13. COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
Muppidi S; Guptill JT; Jacob S; Li Y; Farrugia ME; Guidon AC; Tavee JO; Kaminski H; Howard JF; Cutter G; Wiendl H; Maas MB; Illa I; Mantegazza R; Murai H; Utsugisawa K; Nowak RJ;
Lancet Neurol; 2020 Dec; 19(12):970-971. PubMed ID: 33212055
[No Abstract] [Full Text] [Related]
14. Impact of COVID-19 pandemic and lockdown in a cohort of myasthenia gravis patients in India.
Kalita J; Tripathi A; Dongre N; Misra UK
Clin Neurol Neurosurg; 2021 Mar; 202():106488. PubMed ID: 33460984
[TBL] [Abstract][Full Text] [Related]
15. Respiratory dysfunction as first presentation of myasthenia gravis misdiagnosed as COVID-19.
Scopelliti G; Osio M; Arquati M; Pantoni L
Neurol Sci; 2020 Dec; 41(12):3419-3421. PubMed ID: 33068195
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
Ramaswamy SB; Govindarajan R
J Neuromuscul Dis; 2020; 7(3):361-364. PubMed ID: 32508329
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 pandemic on patients with myasthenia gravis: A survey of the Myasthenia Gravis Foundation of America MG patient registry.
De León AM; Aban I; McPherson T; Granit V; Benatar M; Cutter G; Lee I
Muscle Nerve; 2023 Jan; 67(1):25-32. PubMed ID: 36324261
[TBL] [Abstract][Full Text] [Related]
18. Knowledge and perceptions of the COVID-19 pandemic among patients with myasthenia gravis.
Li Y; Emmett CD; Cobbaert M; Sanders DB; Juel VC; Hobson-Webb LD; Massey JM; Gable KL; Raja SM; Gonzalez NL; Guptill JT
Muscle Nerve; 2021 Mar; 63(3):357-364. PubMed ID: 33280141
[TBL] [Abstract][Full Text] [Related]
19. Telephone consultation for myasthenia gravis care during the COVID-19 pandemic: Assessment of a novel virtual myasthenia gravis index.
Menon D; Alnajjar S; Barnett C; Vijayan J; Katzberg H; Fathi D; Alcantara M; Bril V
Muscle Nerve; 2021 Jun; 63(6):831-836. PubMed ID: 33792967
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.
Peric S; Rankovic M; Bozovic I; Radosavljevic V; Marjanovic I; Basta I; Lavrnic D
Acta Neurol Belg; 2023 Apr; 123(2):529-536. PubMed ID: 36279094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
